Vivanza Biosciences Limited

Operates across three reported business areas: Pharmaceuticals, Agro, and Plastic polymer films, with consolidated FY26 revenue of Rs. 115.91 crore and a net profit of Rs. 0.39 crore. The June 2026 filings disclose a non-binding strategic cooperation and technology transfer agreement to set up a plastic film manufacturing project in the Kyrgyz Republic, covering technology transfer, machinery sourcing, government liaison, investment facilitation, skill development, import-export support, and financing assistance; no monetary consideration has been recorded and a joint venture is only contemplated later. The cost shape is unusual for a manufacturer: materials are shown as 0.0% of revenue, with employee cost at 0.4% and other operating expenses at 0.2% of revenue, suggesting the reported revenue is largely a pass-through or trading activity rather than in-house manufacturing. Operating cash flow on a standalone basis was negative Rs. 121.35 Lacs in FY26, even as the company moved from a loss of Rs. 69.51 Lacs in FY25 to a profit of Rs. 37.50 Lacs on a standalone revenue jump from Rs. 294.28 Lacs to Rs. 11,223.10 Lacs. The company is a micro-cap BSE-listed entity (paid-up equity Rs. 4 crore, net worth Rs. 4.02 crore) headquartered in Ahmedabad, with two promoters holding shares and no encumbrance declared on them.